 |
Regulations of Connecticut State Agencies (Last Updated: June 14,2023) |
 |
Title19a Public Health and Well-being |
|
|
SubTitle19a-72-1_19a-72-5. Connecticut Tumor Registry |
| Sec. 19a-72-1. Connecticut Tumor Registry. Definitions |
|
Latest version.
|
|
As used in this section and sections 19a-72-2 to 19a-72-5, inclusive, of the Regulations of Connecticut State Agencies: (1) “Clinical laboratory” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; (2) “Commissioner” means the Commissioner of Public Health or the Commissioner’s designee; (3) “Connecticut Tumor Registry” means a personal data system maintained and operated by the Department of Public Health that includes a report of every occurrence of a reportable tumor that is diagnosed or treated in the state; (4) “Department” means the Department of Public Health; (5) “Hospital” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; (6) “Health care provider” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; (7) “Industry” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; (8) “Occupation” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; (9) “Reportable tumor” has the same meaning as provided in section 19a-72 of the Connecticut General Statutes; and (10) “Reporting entity” means a hospital, clinical laboratory or health care provider in the state. |
|
(Effective March 8, 2023) |
| Sec. 19a-72-2. Commissioner requirements, reporting entity reporting requirements and case reports |
|
Latest version.
|
|
(a) The Commissioner shall maintain the Connecticut Tumor Registry list of reportable tumors, which shall be posted on the department’s internet website annually, on or before July 1. (b) A reporting entity shall report the following information related to reportable tumors to the department, in the manner set forth in section 19a-72-3 of the Regulations of Connecticut State Agencies: (1) Information prescribed in the standard format set by the North American Association of Central Cancer Registries, as amended from time to time; (2) Initial report and follow-up information required pursuant to section 19a-72 of the Connecticut General Statutes; (3) The diagnostic, treatment, and pathology reports, including, but not limited to, autopsy and cytology reports, results of imaging and radiology tests, diagnosis and stage of disease, surgical and non-surgical treatment methods, tissue diagnosis, and related laboratory data; (4) The reporting entity’s operative or other surgery-related reports, hematology, medical oncology, and radiation therapy notes, or abstracts of such reports or consults and addenda associated with these reports; (5) The patient’s occupation that reflects the specific type of work that an individual, fourteen years of age or older, performed for the longest period of time. Descriptive terms describing the patient’s employment title shall be included when possible, and all other guidelines prescribed by the National Institute for Occupational Safety and Health’s “A Cancer Registrar’s Guide to Collecting Industry and Occupation” shall be applied; (6) Any additional information including patient medical history, history of malignancies in first degree family members, personal identifiers including patient name and social security number, and other information as the department may prescribe; and (7) Follow-up case report information specifying the date of the last contact and the vital statistics of the patient. (c) A reporting entity shall report the information required under subsection (b) of this section for both reportable tumors and annual updates on reportable tumors, and shall submit such information required pursuant to section 19a-72 of the Connecticut General Statutes to the department as one report per calendar month. |
|
(Effective March 8, 2023) |
| Sec. 19a-72-3. Case Reports. Reporting Methods |
|
Latest version.
|
|
(a) Reporting entities shall fulfill the case report reporting requirements of section 19a-72-2 of the Regulations of Connecticut State Agencies by submitting such information electronically, in a format approved by the department. Electronic reports shall be transmitted to the department through a secure, controlled process as prescribed by the department. (b) If tissue samples are submitted to the department in conjunction with the case report, such samples shall be submitted to the department through the department’s designated contractor. |
|
(Effective March 8, 2023) |
| Sec. 19a-72-4. Case Finding and Audits |
|
Latest version.
|
|
(a) The Commissioner may perform an audit of a reporting entity for purposes of case finding to identify reportable diseases, emergency illnesses and health conditions, as defined in section 19a-215 of the Connecticut General Statutes, reportable tumors or other quality improvements to ensure accuracy and completeness of the data reporting. While completing such audit: (1) Any health care provider shall provide the department access to the records of any patient, upon request. (2) Any hospital shall provide the department remote electronic access to all pathology and autopsy reports, including addenda to such reports, accessioned at the hospital upon request. If a hospital has a technical problem providing this level of remote electronic access, the hospital shall work with the department to find a reasonable alternative electronic solution. (3) Any reporting entity shall provide discharge indexes and imaging or radiology reports to the department upon request. (b) If a case is identified by the department as not reported, the health care provider shall have thirty days to provide a case report, or otherwise respond to the audit inquiry. |
|
(Effective March 8, 2023) |
| Sec. 19a-72-5. Special Studies |
|
Latest version.
|
|
(a) The department may, in accordance with section 19a-74 of the Connecticut General Statutes, complete an investigation that includes, but is not limited to, the prevention of, treatment of, and mortality related to cancer. These studies may require collection of supplemental data, or actual tissue samples, necessary to complete the investigation from a reporting entity. (b) Any questionnaire or data form that is distributed to a reporting entity for the purpose of carrying out the investigation made under subsection (a) of this section shall be returned to the department not later than thirty days after the department’s request. |
|
(Effective March 8, 2023) |